GNPX vs MTD · $5.3M cap vs P/E 27, rev $1.97B
Genprex Inc (GNPX) versus Mettler-Toledo International Inc (MTD) — a side-by-side from cached financials, not a winner call.
Genprex Inc (GNPX) is a biotechnology company listed on NASDAQ.
Mettler-Toledo International Inc (MTD) is a diagnostics & research company listed on NYSE.
GNPX does not have a complete income-statement cache yet.
Latest reported MTD revenue for 2026-06-30 was $1.97B. Net income was $402.4M. MTD currently screens at market cap $23.20B and trailing P/E 26.9.
GNPX currently screens at market cap $5.3M. MTD currently screens at market cap $23.20B and trailing P/E 26.9.
Not investment advice. Open the GNPX and MTD stock pages for the full models.
Not investment advice.